戻る
Salarius Pharmaceuticals, Inc. (SLRX)価格
SLRX 株価推移チャート
SLRX 収入
Salarius Pharmaceuticals, Inc.
$0.78
3.93%
$0.02
終値： Jan 23, 16:00:00 GMT-5
$0.78
0%
$0
アフターマーケット：Jan 23, 20:00:00 GMT-5
主要データ
前終値
$0.7505
始値
$0.7948
当日レンジ
$0.77 - $0.84
52週レンジ
$0.5148 - $44.1
取引高
--
平均取引高
3.6M
1株当たり利益(TTM)
-24.24
配当利回り
--
時価総額
$4.5M
Salarius Pharmaceuticals, Inc.とは何ですか？
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2015-01-29. The firm is focused on advancing its pipeline of peptide conjugate therapeutics engineered through its IMP3ACT platform that reduces the complexity of drug development and manufacturing. The company is focused on developing effective treatments for patients with cancer with high, unmet medical needs. The company’s lead candidate, seclidemstat (SP-2577), is being studied as treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options. Its pipeline consists of SP-3164 a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. SP-3164 is a next-generation cereblon-binding MG. SP-2577 is a small-molecule LSD1 inhibitor with a novel scaffold.
